The Executive Board has appointed Peter-Bram ‘t Hoen as professor of Bioinformatics with a focus on Personalized Medicine, and head of the Centre for Molecular and Biomolecular Informatics (CMBI) by 1 March 2018. As such he will be the successor of Gert Vriend.Previously, Peter-Bram 't Hoen worked at the department of Human Genetics, LUMC, Leiden. His main research interest is the impact of genetic variants on transcription, mRNA processing, translation and clinical phenotypes. At the LUMC his research was focused on automated knowledge discovery, enhanced data interoperability and publication, and e-Science approaches to ensure reproducibility and easy sharing of analysis routines. He published over 130 papers in peer-reviewed journals in the area of genetics, bioinformatics, statistics, molecular biology and medicine.
We congratulate Peter-Bram with his new appointment and welcome him to our institute.
Related news items
Miniaturized microfluidic platform for automated epigenetic profiling6 May 2021
Together with Fluidigm, a US-based company focusing on microfluidics, the team of Hendrik Marks publishes in Genome Research the development of a powerful plug and play ChIP-seq platform for minute amount of cells, such as embryonic specimens or small biopsies.read more
Broken teeth coronastress poses a danger to our teeth6 May 2021
Teeth grinding and molars on top of each other: stress from corona causes an increase in dental damage. That's what they noticed at the department of dentistry at Radboudumc.read more
Annual Paper Awards of Research Theme Tumors of the Digestive Tract4 May 2021
The annual Paper Awards session of the Research Theme Tumors of the Digestive Tract took place at the 22nd of April. The selected candidates prepared wonderful informative movies, that were judged by the public of the RRR and by our patient representatives.read more
Dutch Children's Formulary now also in use abroad Drug database for pediatric dosing available online for German, Austrian and Norwegian physicians30 April 2021
The Kinderformularium, developed in the Netherlands, now also provides pediatricians and pharmacists abroad with a database of drug dosage recommendations specifically aimed at treating children.read more
Foundation Fighting Blindness Awards 1.4 million dollars for Rob Collin and Carel Hoyng29 April 2021
Two researchers from the Radboudumc have received a prestigious award from the Translational Research Acceleration Program of the Foundation Fighting Blindness USA.read more
Radboud university medical center appoints thirteen female professors29 April 2021
Their fields of expertise cover the entire (bio-)medical field, ranging from fundamental and translational to clinical research, education and patient care.read more